Use the Tab and Up, Down arrow keys to select menu items.
This course will introduce students to health service contexts and the complexity of care across a range of settings. This is achieved through comprehensive health assessment and the design of care plans leading to considered interventions underpinned by evidence based practice.
Indicative Course Outline- Body systems approach to major acute and long term physical illnesses – aetiology, pathophysiology, treatment and care management- Management of disease including responses to surgical and medical interventions, sick child, infection control, wound, fluid and electrolytes and pain management- Experience of Illness including pre and post-operative care, co-morbidities, living with long term conditions, rehabilitation and community resources- Government health priorities and care rationalisation – the impact on individuals and families / whanau- Introduction to Palliative Care- Evidence based care workshop- Pharmacodynamics, pharmacokinetics, therapeutic drug monitoring- Medications used in treatment of major physical conditions, adverse drug reactions and lifespan considerations
1. Synthesize, integrate and apply the epidemiology, pathophysiology and care management of major physical health changes and the impact these have on individuals and whānau/family in relation to acute, chronic, rehabilitative and palliative phases.2. Critically evaluate and discuss issues associated with chronicity and co-morbidity as it relates to the healthcare and illness experiences of individuals and whānau/family.3. Demonstrate the ability to perform a systematic, competent and culturally safe health assessment in simulated contexts, interpret findings using assessment frameworks and respond to rapidly changing situations and the deteriorating patient.4. Critically evaluate the responsibilities of providing competent nursing care when practicing within the inter-professional health care environment.5. Explain the mechanism of action of selected drug categories and critically discuss care activities which maximise therapeutic effectiveness and minimise adverse reactions.6. Utilise case studies to Integrate knowledge and explain drug interactions, adverse drug reactions and contraindications including complementary medicines.7. Utilise evidence based practice to support best quality health care provision and outcomes in acute and long term health care settings.
Subject to approval of the Head of School of Health Sciences
HLTH455
(W, Th, F): July 18, 19, 20 (M, T, W): Aug 13, 14, 15 (Th, F): Sept 13, 14(M): Oct 3 (exam 9-12)
Thomas Harding
Assessment Information: Assessment 1 – EssayDue date: Wednesday 8th August 1200Word limit:3500 words (excluding references)The incidence of cardiovascular disease and associated mortality in Aotearoa New Zealand has declined over the last 30-40 years; however, the relative burden of disease due to cancer has increased (Costilla, Tobias & Blakely, 2013). Cancer is now the second leading cause of mortality and the cancers with the highest incidence and mortality in Aotearoa New Zealand are lung, colorectal, breast, prostate, melanoma and pancreatic.This assignment requires you to critically reflect on the experience of a person living with cancer, and the role of nursing with respect to this experience.Instructions: Choose one of the cancers listed above andPart A• Briefly outline the epidemiology, and where the cancer you have chosen sits in relation to other cancers (5%)• Describe the pathophysiology of your chosen cancer (20%)• Outline its clinical presentation (10%) • Briefly outline the local support services/community agencies available to support the patient and family/whanau more broadly with respect to this particular cancer (5%).Part BDrawing upon relevant evidence-based literature critically reflect on the experience of people with this condition and how nursing may impact on this experience• Focus on a point in the patient’s trajectory, e.g. diagnosis, treatment, end-of-life, rehabilitation or any other point you consider relevant, and drawing upon the relevant literature critically discuss the impact of the disease on the patient and family/whanau at this point of the trajectory. In your critical discussion you may wish to consider issues pertaining to age, gender, sexuality, ethnicity, spirituality or any other pertinent perspective (30%).• Drawing upon the evidence-based literature critically discuss the role of nursing in supporting the patient and family/whanau at this point (25%).• Five percent (5%) of the overall grade will also be allocated to academic presentation, i.e., referencing, grammar, spelling and structure.You are required to:• Use APA 6th Edition referencing • Submit your work, as a Word document, to ‘Turn-it-in’ via the HLTH468 UCLearn Site on or before the due date.Assessment 2: PresentationDue date: 14, 15 AugustClass room presentation This assessment is designed so you can share with colleagues your in-depth understanding of one pathophysiological condition, its clinical presentation, common medications used in its management, nursing assessment and interventions.Part A 25%Instructions:Prior to attending class on August 13th you will need to familiarise yourself with the pathophysiology, clinical presentation and associated medications from the pharmacology material provided on the HLTH468 LEARN site for the following conditions:- Diabetes (both Type 1 and Type 2)- Coronary Artery Disease- Heart Failure- Asthma- Chronic Obstructive Pulmonary Disease (COPD)- Ischaemic Stroke (CVA)- Osteoporosis- Peptic ulcer disease • You will be randomly allocated into a group of 3-4 students, and randomly allocated a Case Study related to one of the topics from the list above.• As a group you will prepare a 30 minute presentation on your allocated Case Study. The presentation will focus on the pathophysiology of the patient’s presenting illness, clinical presentation, and prescribed medications• On August 14th you will present your Case Study to your fellow students – following each presentation there will be 5 minutes for questions. • NOTE: marks will be allocated individually not to the group.Part B 5%Instructions:• In class on August 15 you will be randomly assigned to a group of 3-4 students, and randomly allocated to a new scenario related to the Case Studies above• You will have two hours to prepare a 15 minute presentation which outlines the nursing assessment to be undertaken, the priority nursing diagnoses and interventions relevant to these diagnoses. Assessment 3: ExaminationDue Date: Monday 3 October 0900-1200. Venue to be advised.This will be 3-hour written examination which will consist of multiple choice questions (MCQ) and short answer questions (SAQ) which will draw from material from text books related to the pathophysiological conditions, pharmacology, the student presentations and other content covered in the 3 teaching blocks.
Adam, Sheila K. et al; Rapid assessment of the acutely ill patient ; Wiley-Blackwell, 2010.
Craft, Judy. , Gordon, Christopher., Tiziani, Adriana; Understanding pathophysiology ; [Australian ed.]; Elsevier Australia, 2011.
DiPiro, Joseph T. et al; Pharmacotherapy : a pathophysiologic approach ; Ninth edition;
Farrell, Maureen et al; Smeltzer & Bare's textbook of medical-surgical nursing ; Third Australian and New Zealand edition; (Volumes 1 and 2 recommended [Note: It is more economical to purchase the two books as a package.]).
Johnstone, Megan-Jane; Bioethics : a nursing perspective ; 5th ed; Churchill Livingstone/Elsevier, 2009.
In addition to your Anatomy and Physiology, Health Assessment and Pharmacology texts from last semester you must have an up to date Medical- Surgical text and a pathophysiological resource on hand. The libraries have useful resources. The following texts are used by the BN students and are available at the bookshop on the ARA campus. The following books from year 1, Stein-Parbury, Patient and Person; Crisp & Taylor, Fundamentals of nursing are also available as e-books at ARA library.
Domestic fee $2,108.00
International Postgraduate fees
* All fees are inclusive of NZ GST or any equivalent overseas tax, and do not include any programme level discount or additional course-related expenses.
For further information see School of Health Sciences .